What is the relationship between marijuana use and symptoms of depression or anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Marijuana Use and Depression/Anxiety: A Complex Bidirectional Relationship

Cannabis use is associated with increased risk for developing depressive disorders and may exacerbate existing psychiatric conditions, particularly in vulnerable individuals, though the relationship appears bidirectional with depression and anxiety also predicting subsequent cannabis use. 1

The Evidence on Cannabis Leading to Depression and Anxiety

The relationship between cannabis use and mental health outcomes shows concerning patterns, though causality remains complex:

Risk of Developing Depression

  • Cannabis use may be associated with increased risk for developing depressive disorders, with this risk correlating with cumulative exposure and age of first use 1
  • Early onset of cannabis use, especially weekly or daily use, strongly predicts not only future dependence but worse psychiatric outcomes 2
  • However, when adjusted for confounding factors (alcohol, other drug use, education, family tension), some longitudinal studies found no statistically significant association between baseline cannabis use and subsequent depression development 3

Risk of Developing Anxiety

  • Cannabis use may exacerbate existing psychiatric disorders in vulnerable individuals, including anxiety 1
  • Older adults who use cannabis may be at higher risk for behavioral health issues, including anxiety and depression 1
  • Age-adjusted analyses show baseline anxiety increases risk of subsequent cannabis use onset (RR=1.63), suggesting reverse causation may be equally or more important 3

The Bidirectional Nature

The evidence strongly suggests that depression and anxiety may actually lead to cannabis use initiation more than the reverse 3:

  • Age-adjusted data shows reporting depression at baseline increased risk of cannabis onset three years later (RR=1.62) 3
  • This bidirectional relationship is stronger among men during adolescence and emerging adulthood, and stronger in women during midlife 4

Critical Considerations About Study Quality

Why the Evidence is Mixed

The conflicting findings stem from methodological issues:

  • Cross-sectional studies consistently show associations between cannabis use and depression/anxiety, but cannot establish causation 5
  • When longitudinal studies adjust for polysubstance use and other confounders, many associations lose statistical significance 3
  • The increasing potency of cannabis products (THC concentration almost doubling from 9% in 2008 to 17% in 2017) means older studies may underestimate current risks 1

High-Dose THC Effects

  • High doses of THC are particularly associated with psychotic symptoms and may worsen psychiatric conditions 1, 2
  • Cannabis concentrates may have THC levels as high as 70%, potentially intensifying adverse mental health effects 1

The Self-Medication Hypothesis

Some evidence suggests patients use cannabis to manage symptoms:

  • One observational trial found medicinal cannabis initiation was associated with significantly decreased anxiety and depressive symptoms 6
  • However, observational and epidemiological studies have not indicated a positive long-term effect of cannabis use on the course and outcome of depression 4
  • There is little evidence to support cannabis as an effective antidepressant despite preclinical suggestions 4

Clinical Implications for Treatment

Impact on Antidepressant Efficacy

It is reasonable to assume that antidepressants are less effective for adolescents with depression/anxiety who frequently use cannabis 7:

  • The mechanisms of action of antidepressants and cannabis show several overlapping pathways that may interfere with treatment 7
  • Almost all randomized clinical trials of antidepressants excluded patients using concomitant cannabis, so real-world effectiveness is poorly characterized 7

Risk of Cannabis Use Disorder

  • Approximately 10% of adults with chronic cannabis use develop cannabis use disorder, characterized by clinically significant impairment or distress 1, 2
  • A randomized trial found participants receiving a medical cannabis card had almost twice the incidence of developing cannabis use disorder within 12 weeks 1

Withdrawal Considerations

  • Long-term daily cannabis users experience withdrawal symptoms after cessation, including irritability, insomnia, sleep disturbances, appetite changes, and abdominal pain 2
  • These symptoms typically occur within 3 days and may last up to 14 days, potentially triggering mood instability 2

Common Pitfalls to Avoid

Do not assume cannabis is therapeutic for depression or anxiety based on patient self-report of symptom relief—the long-term evidence does not support sustained benefit 4. The apparent short-term relief may represent temporary symptom masking while underlying conditions worsen or represent reverse causation where those with worse symptoms seek cannabis.

Do not ignore polysubstance use patterns—much of the association between cannabis and mental health outcomes may be confounded by alcohol and other drug use 3.

Recognize that current high-potency products pose greater risks than historical data suggests—counsel patients accordingly about modern cannabis formulations 1.

References

Guideline

Health Consequences of Marijuana Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Risks of Cannabis Use in Bipolar Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cannabis and Depression.

Advances in experimental medicine and biology, 2021

Related Questions

What is the most appropriate initial investigation for a patient presenting with depression, loss of appetite, social isolation, and non-compliance with anxiety and depression medications, who also exhibits unkempt appearance and slurred speech, and expresses a desire to use marijuana for stress relief?
What is the next step in managing a 35-year-old female with mood swings, irritability, and social withdrawal, using alcohol and marijuana, with a history of depression and anxiety?
What is the most appropriate initial investigation for a patient with depression, anxiety, loss of appetite, and social isolation, who is non-compliant with their antidepressant and anxiolytic medications and wants to use marijuana for stress relief?
What is the most appropriate initial investigation for a patient presenting with depression, loss of appetite, social isolation, and substance use, including marijuana?
What is the most appropriate initial investigation for a patient with depression, loss of appetite, social isolation, anxiety, and non-compliance with prescribed depression medication, who wants to use marijuana for stress relief?
What is a normal right ventricle (RV) to left ventricle (LV) ratio?
What are the indications for steroid and antiviral (valacyclovir) therapy in Bell's palsy?
Does coffee consumption before a blood draw make a clinical difference in laboratory results?
What is the recommended duration of Bactrim (sulfamethoxazole/trimethoprim) treatment for bilateral otitis media?
What are the best antibiotic drops for treating bacterial conjunctivitis?
Is the risk of agranulocytosis with clozapine (clozapine) dose-dependent?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.